Table 2 Patient and tumour characteristics of 309 cases of early breast cancer
Clinico-pathological feature | Distribution (percentage of cases with data) |
|---|---|
Age, years | Â |
 Median | 58 |
 Range | 28−85 |
 <50 | 92 (29.9 %) |
 >50 | 216 (70.1 %) |
Tumour size | Â |
 <2 cm | 114 (41.3 %) |
 2−5 cm | 153 (55.4 %) |
 >5 cm | 9 (3.3 %) |
 Not known | 33 |
LN status | |
 Positive | 132 (46.2 %) |
 Negative | 154 (53.8 %) |
 Not known | 23 |
Histological Grade | Â |
 1 | 56 (20.1 %) |
 2 | 121 (43.4 %) |
 3 | 102 (36.6 %) |
 Not known | 30 |
ER (Estrogen Receptor) status | Â |
 Positive | 226 (75.6 %) |
 Negative | 73 (24.4 %) |
 Not known | 10 |
HER2 status (IHC 3+ or FISH + ve) |  |
 Positive | 26 (16.8 %) |
 Negative | 129 (83.2 %) |
 Not known | 154 |
Recurrence (Local, regional, distant or death when death was known to be caused by breast cancer) | Â |
 Total | 111/309 (35.9 %) |
 Median time to recurrence (years) | 3.14 |
 Range (years) | 0.05−19.05 |
Mortality | Â |
 Total deaths with known cause | 148 |
 Deaths due to breast cancer | 83 (56 %) |
 Deaths with breast cancer present at death | 57 (38.5 %) |
 Deaths due to causes other than breast cancer | 8 (5.4 %) |
 Not known | 12 |
Overall survival (years) | Â |
 Median | 13.48 |
 Range | 0.33−18.11 |
Follow-up (years) | Â |
 Median | 13 |
 Range | 1−17.2 |